Patients

GlaxoSmithKline and Save the Children Join to Save Children’s Lives

By May 10, 2013 July 7th, 2014 No Comments

GlaxoSmithKline (GSK) will join Save the Children in order to fight the leading causes of childhood death worldwide.  GSK will donate $23 million dollars during this 5-year partnership, the main goals being to increase access to medicine and treatment in order to prevent the deaths of infants and children.  These include an antiseptic used to prevent infection in newborns and an antibiotic to treat pneumonia in children.

GSK.SavetheChildren

Read more at Vaccine Nation and the press release here

J. Lewis Research, Inc.

J. Lewis Research, Inc.

We are a unique research company in Salt Lake City with over 25 years of experience conducting clinical trials for the pharmaceutical industry, specializing in Phase II, III and IV clinical trials.